CDI

9 registered clinical trials studyying CDI — 2 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Evaluation of Gut Microbiota and Its Associated Resistome in FMT Donors and Recipients Due to Recurrent Clostr NCT06533800	Fondazione Policlinico Universitario Agostino Gemelli IRCCS	—
Recruiting	VE303 for Prevention of Recurrent Clostridioides Difficile Infection NCT06237452	Vedanta Biosciences, Inc.	Phase 3
Completed	Precision Antimicrobial STewardship for Clostridioides DIfficile Prevention NCT05508607	Intermountain Health Care, Inc.	—
Withdrawn	A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Clostridoides Difficile Infection NCT04100603	ProgenaBiome	—
Withdrawn	Prospective Trial of Oral Vancomycin Therapy vs. Placebo for Prevention of CDI NCT04241744	Creighton University	Phase 4
Completed	The GRAFT Study: Gut RecolonizAtion by Fecal Transplantation NCT03621657	University of Wisconsin, Madison	Phase 2
Completed	Phase 2 Study of VE303 for Prevention of Recurrent Clostridioides Difficile Infection NCT03788434	Vedanta Biosciences, Inc.	Phase 2
Completed	Efficacy of Oral Vancomycin Prophylaxis for Prevention of Recurrent Clostridium Difficile Infection NCT03462459	University of Wisconsin, Madison	Phase 2
Completed	Open-Label Extension of CP101 Trials Evaluating Oral Full-Spectrum Microbiota™ (CP101) in Subjects With Recurr NCT03497806	Finch Research and Development LLC.	Phase 2